Search

Corey, Kristen C, Carol E Cheng, Blair Irwin, and Alexandra B Kimball. 2013. “Self-Reported Help-Seeking Behaviors and Treatment Choices of Adolescents Regarding Acne.”. Pediatric Dermatology 30 (1): 36-41.

Kimball, Alexa Boer. 2012. “Sex, Academics, and Dermatology Leadership: Progress Made, But No More Excuses.”. Archives of Dermatology 148 (7): 844-6.

Tierney, Emily P, William Hanke, and Alexa Boer Kimball. 2011. “Career Trajectory and Job Satisfaction Trends in Mohs Micrographic Surgeons.”. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.] 37 (9): 1229-38.

Kimball, A B, J R Kaczvinsky, J Li, L R Robinson, P J Matts, C A Berge, K Miyamoto, and D L Bissett. 2010. “Reduction in the Appearance of Facial Hyperpigmentation After Use of Moisturizers With a Combination of Topical Niacinamide and N-Acetyl Glucosamine: Results of a Randomized, Double-Blind, Vehicle-Controlled Trial.”. The British Journal of Dermatology 162 (2): 435-41.

Lima, Xinaida T, Elizabeth M Seidler, Hermênio C Lima, and Alexandra B Kimball. 2009. “Long-Term Safety of Biologics in Dermatology.”. Dermatologic Therapy 22 (1): 2-21.

Frangos, Jason E, Christina N Alavian, and Alexa B Kimball. 2008. “Acne and Oral Contraceptives: Update on Women’s Health Screening Guidelines.”. Journal of the American Academy of Dermatology 58 (5): 781-6.

Chang, Anne Lynn S, Joanna Badger, Wingfield Rehmus, and Alexa Boer Kimball. 2008. “Alefacept for Erosive Lichen Planus: A Case Series.”. Journal of Drugs in Dermatology : JDD 7 (4): 379-83.

Holcomb, Zachary E, Monica Rosales Santillan, Peyton C Morss-Walton, Prerna Salian, Min Ji Her, Nicole M Giannotti, Alexa B Kimball, and Martina L Porter. 2020. “Risk of COVID-19 in Dermatologic Patients Receiving Long-Term Immunomodulatory Therapy.”. Journal of the American Academy of Dermatology 83 (4): 1215-18.

Kimball, A B, T Kerbusch, F van Aarle, P Kulkarni, Q Li, A Blauvelt, K A Papp, K Reich, and D Montgomery. 2020. “Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Efficacy and Safety of Tildrakizumab.”. The British Journal of Dermatology 182 (1): 180-89.

Shahwan, K T, and A B Kimball. 2016. “Managing the Dose Escalation of Biologics in an Era of Cost Containment: The Need for a Rational Strategy.”. International Journal of Women’s Dermatology 2 (4): 151-53.